The Close Relationship Between Metabolic Syndrome and Hormone Receptor-Positive Early-Stage Breast Cancer
Objective: The primary aim of the current study was to investigate the frequency of metabolic syndrome (MS) in early-stage breast cancer patients. Additionally, clinicopathological factors, such as anthropometric measurements and hormonotherapy, were examined for their roles as potential confounders...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2023-03-01
|
| Series: | Integrative Cancer Therapies |
| Online Access: | https://doi.org/10.1177/15347354231165938 |
| _version_ | 1797857595755593728 |
|---|---|
| author | Ahmet Ozveren MD Melis Ridvanogullari Donger RD (registered dietitian) Sedat Motor MD Gulcan Bulut MD |
| author_facet | Ahmet Ozveren MD Melis Ridvanogullari Donger RD (registered dietitian) Sedat Motor MD Gulcan Bulut MD |
| author_sort | Ahmet Ozveren MD |
| collection | DOAJ |
| description | Objective: The primary aim of the current study was to investigate the frequency of metabolic syndrome (MS) in early-stage breast cancer patients. Additionally, clinicopathological factors, such as anthropometric measurements and hormonotherapy, were examined for their roles as potential confounders of MS in these patients. Patients and Methods: In this retrospective cross-sectional study, all patients diagnosed with early breast cancer were included. Patients were divided into 2 groups with respect to MS diagnosis. Peripheral blood samples were obtained, clinical data were recorded, and body mass index (BMI) was calculated. Results: The study was completed with a total of 207 patients of which 128 (61.8%) had MS. MS was more frequent hormone receptor positive subgroup and in recipients of adjuvant hormonotherapy. The comparison of patients with and without MS revealed significant differences in age, BMI and estrogen/progesterone receptor status. There were no significant differences between groups in terms of cancer stage, inflammatory markers, basal insulin and LDL levels, and tumor markers. Conclusion: MS appears to be rather widespread among women with early-stage breast cancer, and lifestyle changes, which can improve obesity-related adverse outcomes, should be more emphasized in clinical practice. |
| first_indexed | 2024-04-09T20:59:17Z |
| format | Article |
| id | doaj.art-0c46659787ab41c4950784a5e3530695 |
| institution | Directory Open Access Journal |
| issn | 1552-695X |
| language | English |
| last_indexed | 2024-04-09T20:59:17Z |
| publishDate | 2023-03-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Integrative Cancer Therapies |
| spelling | doaj.art-0c46659787ab41c4950784a5e35306952023-03-29T10:33:23ZengSAGE PublishingIntegrative Cancer Therapies1552-695X2023-03-012210.1177/15347354231165938The Close Relationship Between Metabolic Syndrome and Hormone Receptor-Positive Early-Stage Breast CancerAhmet Ozveren MD0Melis Ridvanogullari Donger RD (registered dietitian)1Sedat Motor MD2Gulcan Bulut MD3Private Izmir Kent Hospital, Izmir, TurkeyPrivate Ankara Guven Hospital, Ankara, TurkeyPrivate Hatay Defne Hospital, Hatay, TurkeyInternational Medicana Hospital, Izmir, TurkeyObjective: The primary aim of the current study was to investigate the frequency of metabolic syndrome (MS) in early-stage breast cancer patients. Additionally, clinicopathological factors, such as anthropometric measurements and hormonotherapy, were examined for their roles as potential confounders of MS in these patients. Patients and Methods: In this retrospective cross-sectional study, all patients diagnosed with early breast cancer were included. Patients were divided into 2 groups with respect to MS diagnosis. Peripheral blood samples were obtained, clinical data were recorded, and body mass index (BMI) was calculated. Results: The study was completed with a total of 207 patients of which 128 (61.8%) had MS. MS was more frequent hormone receptor positive subgroup and in recipients of adjuvant hormonotherapy. The comparison of patients with and without MS revealed significant differences in age, BMI and estrogen/progesterone receptor status. There were no significant differences between groups in terms of cancer stage, inflammatory markers, basal insulin and LDL levels, and tumor markers. Conclusion: MS appears to be rather widespread among women with early-stage breast cancer, and lifestyle changes, which can improve obesity-related adverse outcomes, should be more emphasized in clinical practice.https://doi.org/10.1177/15347354231165938 |
| spellingShingle | Ahmet Ozveren MD Melis Ridvanogullari Donger RD (registered dietitian) Sedat Motor MD Gulcan Bulut MD The Close Relationship Between Metabolic Syndrome and Hormone Receptor-Positive Early-Stage Breast Cancer Integrative Cancer Therapies |
| title | The Close Relationship Between Metabolic Syndrome and Hormone Receptor-Positive Early-Stage Breast Cancer |
| title_full | The Close Relationship Between Metabolic Syndrome and Hormone Receptor-Positive Early-Stage Breast Cancer |
| title_fullStr | The Close Relationship Between Metabolic Syndrome and Hormone Receptor-Positive Early-Stage Breast Cancer |
| title_full_unstemmed | The Close Relationship Between Metabolic Syndrome and Hormone Receptor-Positive Early-Stage Breast Cancer |
| title_short | The Close Relationship Between Metabolic Syndrome and Hormone Receptor-Positive Early-Stage Breast Cancer |
| title_sort | close relationship between metabolic syndrome and hormone receptor positive early stage breast cancer |
| url | https://doi.org/10.1177/15347354231165938 |
| work_keys_str_mv | AT ahmetozverenmd thecloserelationshipbetweenmetabolicsyndromeandhormonereceptorpositiveearlystagebreastcancer AT melisridvanogullaridongerrdregistereddietitian thecloserelationshipbetweenmetabolicsyndromeandhormonereceptorpositiveearlystagebreastcancer AT sedatmotormd thecloserelationshipbetweenmetabolicsyndromeandhormonereceptorpositiveearlystagebreastcancer AT gulcanbulutmd thecloserelationshipbetweenmetabolicsyndromeandhormonereceptorpositiveearlystagebreastcancer AT ahmetozverenmd closerelationshipbetweenmetabolicsyndromeandhormonereceptorpositiveearlystagebreastcancer AT melisridvanogullaridongerrdregistereddietitian closerelationshipbetweenmetabolicsyndromeandhormonereceptorpositiveearlystagebreastcancer AT sedatmotormd closerelationshipbetweenmetabolicsyndromeandhormonereceptorpositiveearlystagebreastcancer AT gulcanbulutmd closerelationshipbetweenmetabolicsyndromeandhormonereceptorpositiveearlystagebreastcancer |